Abstract:Recent studies have suggested that ubiquitin-specific peptidase (USP)18 may act as an oncogene in various types of cancer. Although the role of USP18 in breast cancer cell lines has been elucidated, the underlying mechanisms and clinical role of USP18 in breast cancer are currently not well understood. The bioinformatics analysis and experimental results of the present study demonstrated that aberrant promoter methylation led to increased expression of USP18 in breast cancer. In addition, correlation analysis suggested that a negative correlation between methylation and USP18 mRNA expression was observed in The Cancer Genome Atlas database. USP18 promoted cell proliferation, colony formation and cell cycle progression in vitro. Furthermore, the Gene Set Enrichment Analysis results demonstrated that USP18 may be negatively associated with apoptosis in patients with breast cancer. Bioinformatics analysis results indicated that USP18 was also revealed to be associated with the protein kinase B (AKT) signaling pathway and mammary tumorigenesis in vivo. In addition, the results indicated that USP18 may promote the epidermal growth factor (EGF)-mediated EGF receptor (EGFR)/AKT/S-phase kinase-associated protein 2 (Skp2) pathway by upregulating EGFR and Skp2 in a AKT/forkhead box O3-dependent manner in breast cancer. The results of bioinformatics analysis revealed that increased USP18 expression was associated with a higher TNM stage and unfavorable prognosis in clinical patients. USP18 was also significantly enhanced in patients with human epidermal growth factor receptor 2-positive breast cancer; furthermore, Kaplan-Meier curve demonstrated that combining USP18 and Skp2 expression improved prognostic capability in breast cancer. Taken together, these results suggested that USP18 may serve a key role in breast cancer development by upregulating EGFR and subsequently activating the AKT/Skp2 feedback loop pathway. The role of USP18 in breast cancer provides a novel insight into the clinical application of the USP18/AKT/Skp2 pathway.

Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22–mediated lipolysis circuit

Stress-related hormone reduces autophagy through the regulation of phosphatidylethanolamine in breast cancer cells

Association of EP2 Receptor and SLC19A3 in Regulating Breast Cancer Metastasis.

Epinephrine Increases Malignancy of Breast Cancer Through P38 MAPK Signaling Pathway in Depressive Disorders.

Stress-induced epinephrine promotes hepatocellular carcinoma progression via the USP10-PLAGL2 signaling loop

Stress-induced Epinephrine Enhances Lactate Dehydrogenase A and Promotes Breast Cancer Stem-Like Cells

XBP1s Activates METTL3/METTL14 for ER-phagy and Paclitaxel Sensitivity Regulation in Breast Cancer

A Regulatory Network Analysis of the Importance of USP15 in Breast Cancer Metastasis and Prognosis

Data from Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x–SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis

USP1 Inhibition Destabilizes KPNA2 and Suppresses Breast Cancer Metastasis

USP18 Promotes Breast Cancer Growth by Upregulating EGFR and Activating the AKT/Skp2 Pathway

C/EBPβ/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis.

Adipocyte-Derived Leptin Promotes PAI-1 -Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner

14, 15-EET Induces Breast Cancer Cell EMT and Cisplatin Resistance by Up-Regulating Integrin Αvβ3 and Activating FAK/PI3K/AKT Signaling

USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells

Stabilization of IGF2BP1 by USP10 Promotes Breast Cancer Metastasis Via CPT1A in an M6a-Dependent Manner

USP8 promotes cancer progression and extracellular vesicle‐mediated CD8+ T cell exhaustion by deubiquitinating the TGF‐β receptor TβRII

Adipocyte-derived SFRP5 Inhibits Breast Cancer Cells Migration and Invasion Through Wnt and Epithelial-Mesenchymal Transition Signaling Pathways.

Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer

Adrenergic Receptor Β2 Activation by Stress Promotes Breast Cancer Progression Through Macrophages M2 Polarization in Tumor Microenvironment.

Imbalance of the Reciprocally Inhibitory Loop Between the Ubiquitin-Specific Protease USP43 and EGFR/PI3K/AKT Drives Breast Carcinogenesis